80 related articles for article (PubMed ID: 8619145)
1. A re-evaluation of isotope screening for skeletal metastases in node-negative breast cancer.
Gudgeon CA; Werner ID; Dent DM
S Afr Med J; 1996 Feb; 86(2):166-9. PubMed ID: 8619145
[TBL] [Abstract][Full Text] [Related]
2. Routine bone scanning in patients with T1 and T2 breast cancer: a waste of money.
Yeh KA; Fortunato L; Ridge JA; Hoffman JP; Eisenberg BL; Sigurdson ER
Ann Surg Oncol; 1995 Jul; 2(4):319-24. PubMed ID: 7552621
[TBL] [Abstract][Full Text] [Related]
3. [Value of skeletal scintigraphy in the follow-up of breast cancer].
Langhammer HR; Sondershaus S; Lauer O; Steuer G; Bauer R
Fortschr Med; 1983 Mar; 101(10):429-34. PubMed ID: 6840646
[TBL] [Abstract][Full Text] [Related]
4. Cost efficiency of bone scans in breast cancer.
Kennedy H; Kennedy N; Barclay M; Horobin M
Clin Oncol (R Coll Radiol); 1991 Mar; 3(2):73-7. PubMed ID: 1903301
[TBL] [Abstract][Full Text] [Related]
5. Bone scintigraphy in breast cancer: a ten-year follow-up study.
Crippa F; Seregni E; Agresti R; Bombardieri E; Buraggi GL
J Nucl Biol Med (1991); 1993 Jun; 37(2):57-61. PubMed ID: 8373834
[TBL] [Abstract][Full Text] [Related]
6. Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective?
Wikenheiser KA; Silberstein EB
Cleve Clin J Med; 1996; 63(1):43-7. PubMed ID: 8590515
[TBL] [Abstract][Full Text] [Related]
7. [Skeletal scintigraphy in the care of breast cancer . Long-term follow-up over 8 years].
Anger K; Möller T; Zeimantz E
Strahlentherapie; 1983 Dec; 159(12):745-50. PubMed ID: 6665812
[TBL] [Abstract][Full Text] [Related]
8. Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastases of breast cancer.
Crippa F; Bombardieri E; Seregni E; Castellani MR; Gasparini M; Maffioli L; Pizzichetta M; Buraggi GL
J Nucl Biol Med (1991); 1992; 36(1):52-5. PubMed ID: 1450226
[TBL] [Abstract][Full Text] [Related]
9. Detection of skeletal metastases in Nigerian breast cancer patients: evaluation of radioisotope bone scan and radiography.
Ketiku KK; Azodo MV
West Afr J Med; 1996; 15(2):81-4. PubMed ID: 8924401
[TBL] [Abstract][Full Text] [Related]
10. Bone scintigraphy in breast cancer: a nine-year follow-up.
Kunkler IH; Merrick MV; Rodger A
Clin Radiol; 1985 May; 36(3):279-82. PubMed ID: 4064511
[TBL] [Abstract][Full Text] [Related]
11. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases.
Traill ZC; Talbot D; Golding S; Gleeson FV
Clin Radiol; 1999 Jul; 54(7):448-51. PubMed ID: 10437696
[TBL] [Abstract][Full Text] [Related]
13. Association between bone scintigraphy and serum levels of tumor markers in the detection of bone disease in breast cancer patients.
Zissimopoulos A; Matthaios D; Matthaiou E; Mantadakis E; Karaitianos I
J BUON; 2007; 12(4):505-11. PubMed ID: 18067209
[TBL] [Abstract][Full Text] [Related]
14. The value of serial bone scanning in operable breast cancer.
Monypenny IJ; Grieve RJ; Howell A; Morrison JM
Br J Surg; 1984 Jun; 71(6):466-8. PubMed ID: 6722488
[TBL] [Abstract][Full Text] [Related]
15. Association between number and sites of new bone scan abnormalities and presence of skeletal metastases in patients with breast cancer.
Jacobson AF; Stomper PC; Jochelson MS; Ascoli DM; Henderson IC; Kaplan WD
J Nucl Med; 1990 Apr; 31(4):387-92. PubMed ID: 2324816
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of whole-body MRI and bone scintigraphy in the detection of osseous metastases in patients with breast cancer--A Prospective Double-Blinded Study at two Hospital Centers].
Ohlmann-Knafo S; Kirschbaum M; Fenzl G; Pickuth D
Rofo; 2009 Mar; 181(3):255-63. PubMed ID: 19229791
[TBL] [Abstract][Full Text] [Related]
17. [Skeletal scintigraphy in the follow-up of breast cancer. Statistical and epidemiological viewpoints].
Hölzel D; Thieme C
Dtsch Med Wochenschr; 1986 Aug; 111(31-32):1191-9. PubMed ID: 3732072
[TBL] [Abstract][Full Text] [Related]
18. [Should systematic bone scintigraphy be carried out on breast cancer patients with small tumors?].
Lagrange JL; Frenay M; Darcourt J; François E; Héry M; Namer M; Lapalus F
J Gynecol Obstet Biol Reprod (Paris); 1990; 19(6):701-8. PubMed ID: 2258588
[TBL] [Abstract][Full Text] [Related]
19. Scintigraphic and radiographic patterns of skeletal metastases in breast cancer: value of sequential imaging in predicting outcome.
Janicek MJ; Shaffer K
Skeletal Radiol; 1995 Nov; 24(8):597-600. PubMed ID: 8614859
[TBL] [Abstract][Full Text] [Related]
20. [Reliability of CA 15-3 in the follow up of female patients with breast carcinoma and bone metastases].
del Rocío Estrada-Sánchez G; Mireles Enríquez M; Valverde Castañeda N
Rev Invest Clin; 2003; 55(4):412-8. PubMed ID: 14635605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
